Best Practices in Managing Cardiac Toxicity in the Cancer Patient: The Cardiologist's Perspective

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Best Practices in Managing Cardiac Toxicity in the Cancer Patient: The Cardiologist's Perspective

By Scripps Health FEATURING Margot Davis

24 views

November 21, 2023

Comments 0

Embracing the Importance of HFrEF and HFpEF GDMT

Feat. M. Budoff

Timely Implementation of HFrEF GDMT

Feat. N. Singh

Diversity in Medicine: Are There Racial Differences in Treatment Out…

Houston Methodist DeBakey Heart and Vascular Center

C. Yancy

3.1K views

3 years ago

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

1.4K views

4 weeks ago

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

ACHL

M. Vaduganathan

877 views

11 months ago

Treatment of Iron Deficiency Across the Heart Failure Spectrum

ACHL

S. Gale

775 views

11 months ago

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

182 views

8 months ago

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

5.4K views

2 years ago

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

109 views

8 months ago

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

96 views

8 months ago

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

669 views

1 year ago

2023 Update on Cardiac Amyloid

MUSC Cardiology

J. Griffin

433 views

1 year ago

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

107 views

3 months ago

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

138 views

6 months ago

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

466 views

1 year ago

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

103 views

8 months ago

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

50 views

8 months ago

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

84 views

8 months ago

Iron Deficiency Cases and Panel Discussions

ACHL

A. Mardis, S. Gale, M. Vaduganathan

94 views

11 months ago

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

94 views

8 months ago

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

403 views

1 year ago

Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sig…

Courage and Innovation Symposium: Heart Failure & Heart Transplantation

N. Sarswat

1.3K views

2 years ago

AUTOPLAY

Login

Login

Join VuMedi

Best Practices in Managing Cardiac Toxicity in the Cancer Patient: The Cardiologist's Perspective

Embracing the Importance of HFrEF and HFpEF GDMT

Timely Implementation of HFrEF GDMT

Recommended

Diversity in Medicine: Are There Racial Differences in Treatment Out…

Intravenous Iron for Heart Failure: Where Is the Evidence?

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

Treatment of Iron Deficiency Across the Heart Failure Spectrum

Cardiotoxicity in Breast Cancer – Case Discussion

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Cardio-Oncology: Definitions and Scope

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

2023 Update on Cardiac Amyloid

How the Experts Manage: Cardiotoxicity and IO in NSCLC

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ADT for Prostate Cancer and Cardiovascular Health Considerations

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Cardiotoxicity in Melanoma – Case Discussion

Cardiotoxicity in RCC – Case Discussion

Iron Deficiency Cases and Panel Discussions

Cardiac Disease in Breast Cancer: Background & Risk Factors

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Updates on Cardiac Amyloidosis: A “Rare” Disease Hiding in Plain Sig…